# Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients

> **NCT00002049** · NA · COMPLETED · sponsor: **Immunobiology Research Institute**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Thymopentin

## Key facts

- **NCT ID:** NCT00002049
- **Lead sponsor:** Immunobiology Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002049, "Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*